These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 17646583

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T, Chung J, Doolan A, Nguyen L, Williams IA, Tu E, Lam L, Bailey CG, Rasko JE, Allen DG, Semsarian C.
    J Mol Cell Cardiol; 2006 Oct; 41(4):623-32. PubMed ID: 16950368
    [Abstract] [Full Text] [Related]

  • 23. Abnormal conduction and repolarization in late-activated myocardium of dyssynchronously contracting hearts.
    Spragg DD, Akar FG, Helm RH, Tunin RS, Tomaselli GF, Kass DA.
    Cardiovasc Res; 2005 Jul 01; 67(1):77-86. PubMed ID: 15885674
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
    Eom GH, Cho YK, Ko JH, Shin S, Choe N, Kim Y, Joung H, Kim HS, Nam KI, Kee HJ, Kook H.
    Circulation; 2011 May 31; 123(21):2392-403. PubMed ID: 21576649
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart.
    Parlakian A, Charvet C, Escoubet B, Mericskay M, Molkentin JD, Gary-Bobo G, De Windt LJ, Ludosky MA, Paulin D, Daegelen D, Tuil D, Li Z.
    Circulation; 2005 Nov 08; 112(19):2930-9. PubMed ID: 16260633
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through beta 2-adrenoceptors.
    Foerster K, Groner F, Matthes J, Koch WJ, Birnbaumer L, Herzig S.
    Proc Natl Acad Sci U S A; 2003 Nov 25; 100(24):14475-80. PubMed ID: 14612574
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mechanisms of disease: ion channel remodeling in the failing ventricle.
    Nass RD, Aiba T, Tomaselli GF, Akar FG.
    Nat Clin Pract Cardiovasc Med; 2008 Apr 25; 5(4):196-207. PubMed ID: 18317475
    [Abstract] [Full Text] [Related]

  • 39. Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling.
    Lorenz K, Schmitt JP, Vidal M, Lohse MJ.
    Int J Biochem Cell Biol; 2009 Dec 25; 41(12):2351-5. PubMed ID: 19666137
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.